scholarly article | Q13442814 |
P2093 | author name string | Lee YH | |
Chen SY | |||
Shih CM | |||
Miyamura T | |||
Lo SJ | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose | Q24299251 | ||
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
Expression and identification of hepatitis C virus polyprotein cleavage products | Q27486022 | ||
Structure and organization of the hepatitis C virus genome isolated from human carriers | Q27486168 | ||
Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells | Q27486219 | ||
Expression of processed core protein of hepatitis C virus in mammalian cells | Q27486227 | ||
Genetic organization and diversity of the hepatitis C virus | Q27860507 | ||
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 | ||
Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B. | Q42984888 | ||
Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers | Q42986433 | ||
The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers | Q42988129 | ||
Cloned HBV DNA causes hepatitis in chimpanzees | Q44284928 | ||
Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis A virus and chronic hepatitis B virus infections | Q45795849 | ||
Non-A, non-B hepatitis in persistent carriers of hepatitis B virus | Q45795852 | ||
Domains of simian virus 40 large T-antigen exposed on the cell surface | Q45805091 | ||
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma | Q45844527 | ||
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis | Q45844531 | ||
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience | Q45850894 | ||
Hepatitis C virus infection in patients with nonalcoholic chronic liver disease | Q45852315 | ||
SPXX, a frequent sequence motif in gene regulatory proteins | Q69209195 | ||
18 Hybridization of denatured RNA transferred or dotted to nitrocellulose paper | Q72712861 | ||
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis | Q27860603 | ||
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis | Q27860811 | ||
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis | Q27860909 | ||
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma | Q28131791 | ||
Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene | Q28776291 | ||
Ribonucleic acid isolated by cesium chloride centrifugation | Q29616561 | ||
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium | Q29617962 | ||
Protein kinase recognition sequence motifs | Q29620224 | ||
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups | Q29620772 | ||
Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions | Q29620803 | ||
Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes | Q29620921 | ||
The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen | Q33334884 | ||
Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. | Q34596607 | ||
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. | Q34617048 | ||
Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers | Q35855115 | ||
The regulation of transcription by phosphorylation | Q36377421 | ||
Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus | Q36645120 | ||
Phosphorylation of hepatitis B virus precore and core proteins | Q36688608 | ||
Hepatitis B virus X protein is not central to the viral life cycle in vitro | Q36690826 | ||
Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein | Q36698941 | ||
Phosphorylation of the budgerigar fledgling disease virus major capsid protein VP1 | Q36699152 | ||
Pregenomic RNA encapsidation analysis of eleven missense and nonsense polymerase mutants of human hepatitis B virus | Q36701104 | ||
Differential formation of disulfide linkages in the core antigen of extracellular and intracellular hepatitis B virus core particles | Q36701836 | ||
A system for studying the selective encapsidation of hepadnavirus RNA. | Q36831014 | ||
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity | Q36871938 | ||
In vivo phosphorylation and protein analysis of hepatitis B virus core antigen | Q36886094 | ||
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P | Q37111884 | ||
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma | Q39243681 | ||
Protein import into the cell nucleus | Q39760608 | ||
Phosphorylation of vaccinia virus core proteins during transcription in vitro | Q40063067 | ||
The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. | Q40116164 | ||
RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication | Q40309060 | ||
Expression and replication of the hepatitis B virus genome under foreign promoter control | Q40562223 | ||
The proteins of hepatitis B dane particle cores | Q40674307 | ||
Evidence for involvement of a ribosomal leaky scanning mechanism in the translation of the hepatitis B virus pol gene from the viral pregenome RNA. | Q41116015 | ||
Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma | Q41200053 | ||
Hepatitis delta antigen expressed by recombinant baculoviruses: comparison of biochemical properties and post-translational modifications between the large and small forms | Q41603897 | ||
The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA | Q42599039 | ||
Role of Hepatitis C Virus Infection in Spontaneous Hepatitis B Surface Antigen Clearance during Chronic Hepatitis B Virus Infection | Q42981223 | ||
The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. | Q42984320 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virus | Q808 |
Hepatitis B virus | Q6844 | ||
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
hepatitis B | Q6853 | ||
P304 | page(s) | 5823-5832 | |
P577 | publication date | 1993-10-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells | |
P478 | volume | 67 |
Q27477956 | Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV |
Q33617717 | Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population |
Q27485987 | Biosynthesis and biochemical properties of the hepatitis C virus core protein |
Q35868307 | Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly. |
Q40291207 | Causal Mediation Analysis of Survival Outcome with Multiple Mediators |
Q46846954 | Clearance of chronic HCV infection during acute delta hepatitis. |
Q33801311 | Clinical implications of hepatitis B virus mutations: recent advances |
Q27480298 | DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid |
Q90262252 | Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection |
Q24653498 | Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor |
Q37466211 | Dual chronic hepatitis B virus and hepatitis C virus infection |
Q27469586 | Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors |
Q42984530 | Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV)-related cirrhosis. Virological features of HBV-HCV dual infection |
Q34769530 | Effects of HCV on basal and tat-induced HIV LTR activation |
Q27488825 | Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China |
Q26751031 | Genetic variation of occult hepatitis B virus infection |
Q38805093 | Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals |
Q34485074 | Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection |
Q54211677 | Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). |
Q34404975 | Hepatitis B virus and hepatitis C virus dual infection |
Q42228388 | Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics |
Q27472769 | Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection |
Q27480393 | Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype |
Q33642411 | Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. |
Q22009013 | Hepatitis C virus core protein interacts with cellular putative RNA helicase |
Q24313170 | Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor |
Q27481061 | Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets |
Q43047202 | Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers |
Q36642065 | Hepatitis C: progress and problems |
Q34730208 | Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies |
Q35356183 | High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan |
Q27473384 | Homotypic interaction and multimerization of nucleocapsid protein of tomato spotted wilt tospovirus: identification and characterization of two interacting domains |
Q27469606 | Identification of Residues in the Hepatitis C Virus Core Protein That Are Critical for Capsid Assembly in a Cell-Free System |
Q34757394 | Influence of occult hepatitis B virus infection in chronic hepatitis C outcomes |
Q34425267 | Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo |
Q27469747 | Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation |
Q36920164 | Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C |
Q33674042 | Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection |
Q35664183 | Management of chronic hepatitis B in patients from special populations |
Q33594457 | Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis |
Q40823860 | Mediation effect of hepatitis B and C on mortality. |
Q35832747 | Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation |
Q33983949 | Molecular biology of hepatitis C infection |
Q35094277 | Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand |
Q24815355 | Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection |
Q42980329 | Nuclear localization of nucleocapsid-like particles and HCV core protein in hepatocytes of a chronically HCV-infected patient |
Q37798473 | Occult Hepatitis B: Clinical Implications and Treatment Decisions |
Q35100009 | Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C. |
Q41774248 | Occult hepatitis B in blood donors: a description of two cases |
Q37606222 | Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection |
Q34387913 | Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy |
Q37511339 | Prevalence and determinants of hepatitis B antigenemia in 15,007 inmates in Taiwan |
Q77073351 | Prevalence of hepatitis B markers in patients with hepatitis C infection in north-eastern Poland: risk factors and vaccine use |
Q27480775 | Regulated processing of hepatitis C virus core protein is linked to subcellular localization |
Q27481454 | Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway |
Q35793834 | Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population |
Q36195013 | Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients: A Large Cohort Retrospective Study. |
Q24564165 | Sequence analysis of the core gene of 14 hepatitis C virus genotypes |
Q34174479 | Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa |
Q35667068 | Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient |
Q40065924 | Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers. |
Q34105421 | The heterogeneous nuclear ribonucleoprotein K (hnRNP K) interacts with dengue virus core protein |
Q36575228 | The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. |
Q27469583 | The native form and maturation process of hepatitis C virus core protein |
Q31076773 | Transactivating effect of hepatitis C virus core protein: a suppression subtractive hybridization study |
Q36804532 | Transcription factor YY1 and its associated acetyltransferases CBP and p300 interact with hepatitis delta antigens and modulate hepatitis delta virus RNA replication |
Q27469762 | Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein |
Q21245597 | Viral hepatitis and hepatocellular carcinoma |
Q56896375 | Viral hepatitis in hemodialysis: An update |
Q42984120 | Viral replication in patients with concomitant hepatitis B and C virus infections |
Search more.